SCHEMBL7567066

SCHEMBL7567066

C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(O)c4cccs4)CC[C@@H]23)CC(O[Si](C)(C)C(C)(C)C)CC1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VDR P11473 7/20 0.51
▸ MAPT P10636 5/20 0.50
▸ ADORA3 P0DMS8 3/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ SLC6A2 P23975 2/20 0.50
▸ AGTR1 P30556 2/20 0.50
▸ PGR P06401 2/20 0.50
▸ NR1I2 O75469 1/20 0.50
▸ ABCB11 O95342 1/20 0.50
▸ GC P02774 1/20 0.50
▸ RXRA P19793 1/20 0.50
▸ CHRM3 P20309 1/20 0.50
▸ CNR1 P21554 1/20 0.50
▸ HTR2C P28335 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ SLC6A4 P31645 1/20 0.50
▸ ADRA1A P35348 1/20 0.50
▸ PTGS2 P35354 1/20 0.50
▸ OPRD1 P41143 1/20 0.50
▸ OPRK1 P41145 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5685116 1.00 VDR (0.51) VDRMAPTADORA3SMN1; SMN2SLC6A2
SCHEMBL5682678 0.97 VDR (0.48) VDRMAPTADORA3SMN1; SMN2SLC6A2
SCHEMBL5685232 0.91 VDR (0.47) VDRMAPTADORA3SMN1; SMN2SLC6A2
SCHEMBL5682384 0.89 VDR (0.50) VDRMAPTADORA3SMN1; SMN2SLC6A2
SCHEMBL5681032 0.89 VDR (0.53) VDR
SCHEMBL5681044 0.89 VDR (0.51) VDRMAPTADORA3SMN1; SMN2SLC6A2
SCHEMBL5681008 0.89 VDR (0.51) VDRMAPTADORA3SMN1; SMN2SLC6A2
SCHEMBL7568252 0.87 VDR (0.47) VDRMAPTADORA3SMN1; SMN2SLC6A2
SCHEMBL7568262 0.87 VDR (0.47) VDRMAPTADORA3SMN1; SMN2SLC6A2
SCHEMBL5684984 0.87 VDR (0.47) VDRMAPTADORA3SMN1; SMN2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1210327-A2 NEW VITAMIN D DERIVATIVES WITH CYCLIC SUBSTRUCTURES IN THE SIDE CHAINS, METHOD AND INTERMEDIATES FOR THEIR PRODUCTION AND THEIR USE IN THE PREPARATION OF MEDICAMENTS Schering Aktiengesellschaft (DE) 2002-06-05 — — EP disclosed
WO-2001007405-A2 NEW VITAMIN D DERIVATIVES WITH CYCLIC SUBSTRUCTURES IN THE SIDE CHAINS, METHOD AND INTERMEDIATES FOR THEIR PRODUCTION AND THEIR USE IN THE PREPARATION OF MEDICAMENTS SCHERING AKTIENGSELLSCHAFT (DE) 2001-02-01 — — WO disclosed
Send feedback